Allen Patricia L's Form 4 filing
Zenas BioPharma, Inc. (ZBIO) · filed Feb 13, 2026
- Accession no.
- 0001104659-26-015342
- Filed
- Feb 13, 2026
- Trade date
- Feb 12-13, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $499.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Allen Patricia LCIK 0001348587 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Common Stock | PPurchaseAcquired | +5,000 | $23.77 | +$118,850 | 5,000 | Direct | |
| Feb 12, 2026 | Common Stock | PPurchaseAcquired | +5,700 | $24.34 | +$138,738 | 10,700 | Direct | |
| Feb 12, 2026 | Common Stock | PPurchaseAcquired | +5,000 | $26.50 | +$132,500 | 15,700 | Direct | |
| Feb 13, 2026 | Common Stock | PPurchaseAcquired | +4,160 | $26.36 | +$109,657.6 | 19,860 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.